课题基金 / 基金详情

Analysis of mechanism of the induction of apoptosis induced by the toxin derived form periodontopathic bacteria and its intracellular signal transduction

Analysis of mechanism of the induction of apoptosis induced by the toxin derived form periodontopathic bacteria and its intracellular signal transduction
牙周病菌毒素诱导细胞凋亡机制及细胞内信号转导分析
批准号:
11671834
负责人:
NISHIHARA Tatsuji
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

NISHIHARA Tatsuji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The cytolethal distending toxin (CDT) from Actinobacillus actinomycetemcomitans was previously shown to induce cell cycle arrest in G2/M phase in Hela cells. In the present study, we demonstrated that the CDT from A.actinomycetemcomitans induced G2 cell cycle arrest in the B cell hybridoma cell line, HS-72 by flow cytometric analysis. The mechanism of CDT-induced cell cycle arrest was investigated using HS-72 cells. The CDT up-regulated the expression of cyclin-dependent kinase inhibitor p21CIP1/WAF1 and tumor-suppressor protein p53. The ectopic expression of human papilloma virus type-16 E6/E7 abolished the CDT-induced expression of p53. However, E6/E7 expression had no effect on the expression of p21CIP1/WAF1 and G2 cell cycle arrest in HS-72 cells cultured with the CDT.Furthermore, overexpression of adominant negative p53 mutant did not inhibit the CDT-mediated p21CIP1/WAF1 expression and G2 cell cycle arrest in HS-72 cells. These results indicate that the CDT from A.actinomycetemcomitans induce p21CIP1/WAF1 expression and G2 cell cycle arrest in B lineage cells by p53-independent pathways. Together with additional observations on Hela and COS-1 cells cultured with the CDT from A.actinomycetemcomitans, the results in the present study suggest the CDT-induced p21CIP1/WAF1 may promote G2 cell cycle arrest in mammmalian cells.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Yamamoto,S.et al.: "Anti-proliferative capsular-like polysaccharide antigen from Actinobacillus actinomycetemcomitans"J.Dent.Res.. 78. 1230-1237 (1999)
Yamamoto,S.et al.:“来自放线杆菌放线菌伴生的抗增殖荚膜样多糖抗原”J.Dent.Res.78.1230-1237(1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Muto,A.et al.: "1,25-Dihydroxyvitamin D_3 induces differentiation of retinoic acid-resistant APL cell line (UF-1)"Blood. 93. 2225-2233 (1999)
Muto,A.等人:“1,25-二羟基维生素 D_3 诱导视黄酸抗性 APL 细胞系 (UF-1) 的分化”血液。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kobayashi, M., N.Okada, Y.Okamatsu, K.Mugikura, T.Nishihara, S.Hanazawa, S.Kitano, and K.Hasegawa.: "Intracellular interleukin-1α production in human gingival fibroblasts is differentially regulated by various cytokines."J.Dent.Res.. 78. 840-849 (1999)
Kobayashi, M., N.Okada, Y.Okamatsu, K.Mugikura, T.Nishihara, S.Hanazawa, S.Kitano, and K.Hasekawa.:“人牙龈成纤维细胞中细胞内白细胞介素 1α 的产生受到多种因素的差异调节。细胞因子。”J.Dent.Res..78. 840-849 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Development of biopolymer compound to elucidate the effect of glucan on innate immune system
    • 批准号:
      24659841
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      NISHIHARA Tatsuji
    • 依托单位:
    Development of periodontal disease-diagnosis kit by nanotechnology and the application for information on health network
    • 批准号:
      20390531
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2008
    • 负责人:
      NISHIHARA Tatsuji
    • 依托单位:
    Molecular biological analysis of sensitivity and individual differences in cardiovascular diseases induced by periodontopathic bacteria
    • 批准号:
      18390562
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.19万
    • 财政年份:
      2006
    • 负责人:
      NISHIHARA Tatsuji
    • 依托单位:
    Molecular biological analysis of the exotoxin derived from periodontopathic bacteria on peridontal medicine
    • 批准号:
      16390615
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.19万
    • 财政年份:
      2004
    • 负责人:
      NISHIHARA Tatsuji
    • 依托单位:
    海外基金